Ocular vascular thrombotic events: A diagnostic window to familial thrombophilia (compound factor V Leiden and prothrombin gene heterozygosity) and thrombosis

Clinical and Applied Thrombosis/Hemostasis

Volumn 15, Issue 1, 2009, Pages 12-18

  Glueck, Charles J ^a,b   Wang, Ping ^a  

^a JEWISH HOSPITAL   (United States)

^b Cholesterol Center   (United States)

Author keywords

Familial thrombophilia; G1691A factor V Leiden; G20210A prothrombin; Ocular thrombosis; Thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; GLYCOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET GLYCOPROTEIN PLA1A2; PROTHROMBIN; UNCLASSIFIED DRUG; WARFARIN;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; CEREBROVASCULAR ACCIDENT; CHILD; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENETIC SCREENING; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; ISCHEMIC OPTIC NEUROPATHY; LUNG EMBOLISM; MALE; MESENTERIC ARTERY; PERTHES DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOPHILIA; TRANSIENT ISCHEMIC ATTACK; TRANSITIONAL BLINDNESS;

ADULT; AMAUROSIS FUGAX; FACTOR V; HUMANS; MALE; OPTIC NEUROPATHY, ISCHEMIC; PEDIGREE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; PROTHROMBIN; PULMONARY EMBOLISM; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 58449084382     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029608321438     Document Type: Article

References (62)

1. Greiner K., Hafner G., Dick B., Peetz D., Prellwitz W., Pfeiffer N. Retinal vascular occlusion and deficiencies in the protein C pathway. Am J Ophthalmol. 1999 ; 128: 69-74.
2. Hansen L., Kristensen HL, Bek T., Ingerslev J. Markers of thrombophilia in retinal vein thrombosis. Acta Ophthalmol Scand. 2000 ; 78: 523-526.
3. Larsson J., Hillarp A., Olafsdottir E., Bauer B. Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion. Acta Ophthalmol Scand. 1999 ; 77: 634-637.
4. Pianka P., Almog Y., Man O., Goldstein M., Sela BA, Loewenstein A. Hyperhomocysteinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology. 2000 ; 107: 1588-1592.
5. Klein R., Klein BE, Moss SE, Meuer SM The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000 ; 98: 133-141.
6. Wenzler EM, Rademakers AJ, Boers GH, Cruysberg JR, Webers CA, Deutman AF Hyperhomocysteinemia in retinal artery and retinal vein occlusion. Am J Ophthalmol. 1993 ; 115: 162-167.
7. von Mach MA, Guz A., Wiechelt J., Pfeiffer N., Weilemann LS Systemic fibrinolytic therapy using urokinase in central retinal artery occlusion. A case study. Dtsch Med Wochenschr. 2005 ; 130: 1002-1006.
8. Ozdek S., Yulek F., Gurelik G., Aydin B., Hasanreisoglu B. Simultaneous central retinal vein and retinal artery branch occlusions in two patients with homocystinaemia. Eye. 2004 ; 18: 942-945.
9. Ben-Ami R., Zeltser D., Leibowitz I., Berliner SA Retinal artery occlusion in a patient with factor V Leiden and prothrombin G20210A mutations. Blood Coagul Fibrinolysis. 2002 ; 13: 57-59.
10. Vielpeau I., Le Hello C., Legris A., Salsou E., Lecoq PJ Retinal vascular occlusion and primary antiphospholipid syndrome. Report of 2 cases. J Fr Ophtalmol. 2001 ; 24: 955-960.
11. Salomon O., Huna-Baron R., Moisseiev J., et al. Thrombophilia as a cause for central and branch retinal artery occlusion in patients without an apparent embolic source. Eye. 2001 ; 15: 511-514.
12. Greiner K., Peetz D., Winkgen A., Prellwitz W., Pfeiffer N., Hafner G. Genetic thrombophilia in patients with retinal vascular occlusion. Int Ophthalmol. 1999 ; 23: 155-160.
13. Bertram B., Remky A., Arend O., Wolf S., Reim M. Protein C, protein S, and antithrombin III in acute ocular occlusive diseases. Ger J Ophthalmol. 1995 ; 4: 332-335.
14. Czerlanis C., Jay WM, Nand S. Inherited thrombophilia and the eye. Semin Ophthalmol. 2008 ; 23: 111-119.
15. Akar N., Gokce H. High levels of FVIII and FIX in a pediatric patient with retinal artery occlusion. Pediatr Hematol Oncol. 2002 ; 19: 593-595.
16. Glueck CJ, Fontaine RN, Wang P. Interaction of heritable and estrogen-induced thrombophilia: possible etiologies for ischemic optic neuropathy and ischemic stroke. Thromb Haemost. 2001 ; 85: 256-259.
17. Glueck CJ, Wang P., Bell H., Rangaraj V., Goldenberg N. Nonarteritic anterior ischemic optic neuropathy: associations with homozygosity for the C677T methylenetetrahydrofolate reductase mutation. J Lab Clin Med. 2004 ; 143: 184-192.
18. Larsson J. Central retinal artery occlusion in a patient homozygous for factor V Leiden. Am J Ophthalmol. 2000 ; 129: 816-817.
19. Leifert D., Auw-Hadrich C., Leifert JA Arterial ocular occlusion associated with systemic venous thrombophilia-2 case reports. Klin Monatsbl Augenheilkd. 2006 ; 223: 908-913.
20. Srinivasan S., Fern A., Watson WH, McColl MD Reversal of nonarteritic anterior ischemic optic neuropathy associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutation. Am J Ophthalmol. 2001 ; 131: 671-673.
21. Glueck CJ, Goldenberg N., Bell H., Golnik K., Wang P. Amaurosis fugax: associations with heritable thrombophilia. Clin Appl Thromb Hemost. 2005 ; 11: 235-241.
22. Bick RL, Alfar H., Goedecke C. Thrombophilic causes of retinal vascular thrombosis: etiology and treatment outcomes. Clin Appl Thromb Hemost. 2002 ; 8: 315-318.
23. Glueck CJ, Wang P., Hutchins R., Petersen MR, Golnik K. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions [published online ahead of print December 26, 2007]. Clin Appl Thromb Hemost. doi:10.1177/1076029607304726.
24. Glueck CJ, Golnik K., Ping W. Amaurosis fugax caused by heritable thrombophilia-hypofibrinolysis in cases without carotid atherosclerosis: thromboprophylaxis prevents subsequent transient monocular partial blindness. Clin Appl Thromb Hemost. 2007 ; 13: 124-129.
25. Nagy V., Steiber Z., Takacs L., et al. Trombophilic screening for nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2006 ; 244: 3-8.
26. Randhawa S., Van Stavern GP Sticky platelet syndrome and anterior ischaemic optic neuropathy. Clin Exp Ophthalmol. 2007 ; 35: 779-781.
27. Salomon O., Huna-Baron R., Kurtz S., et al. Analysis of pro-thrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 1999 ; 106: 739-742.
28. Glueck CJ, Bell H., Vadlamani L., et al. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion. Arch Ophthalmol. 1999 ; 117: 43-49.
29. Glueck CJ, Wang P., Bell H., Rangaraj V., Goldenberg N. Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion. Clin Appl Thromb Hemost. 2005 ; 11: 375-389.
30. Arsene S., Delahousse B., Regina S., Le Lez ML, Pisella PJ, Gruel Y. Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age. Thromb Haemost. 2005 ; 94: 101-106.
31. Janssen MC, den Heijer M., Cruysberg JR, Wollersheim H., Bredie SJ Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost. 2005 ; 93: 1021-1026.
32. Incorvaia C., Bandello F., Parmeggiani F., D'Angelo S., Costagliola C., Sebastiani A. Recurrent central retinal vein occlusion in a young thrombophilic patient with factor V Leiden mutation. Eur J Ophthalmol. 2002 ; 12: 131-134.
33. Rodeghiero F., Tosetto A. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism. Ann Intern Med. 1999 ; 130: 643-650.
34. Glueck CJ, Freiberg RA, Fontaine RN, Sieve-Smith L., Wang P. Anticoagulant therapy for osteonecrosis associated with heritable hypofibrinolysis and thrombophilia. Expert Opin Investig Drugs. 2001 ; 10: 1309-1316.
35. Balasa VV, Gruppo RA, Glueck CJ, et al. Legg-Calve-Perthes disease and thrombophilia. J Bone Joint Surg Am. 2004 ; 86A: 2642-2647.
36. Glueck CJ, Pranikoff J., Aregawi D., et al. The factor V Leiden mutation, high factor VIII, and high plasminogen activator inhibitor activity: etiologies for sporadic miscarriage. Metabolism. 2005 ; 54: 1345-1349.
37. Glueck CJ, Wang P., Bornovali S., Goldenberg N., Sieve L. Polycystic ovary syndrome, the G1691A factor V Leiden mutation, and plasminogen activator inhibitor activity: associations with recurrent pregnancy loss. Metabolism. 2003 ; 52: 1627-1632.
38. Current management of amaurosis fugax. The Amaurosis Fugax Study Group. Stroke. 1990 ; 21: 201-208.
39. McGwin G. Jr, Vaphiades MS, Hall TA, Owsley C. Nonarteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction. Br J Ophthalmol. 2006 ; 90: 154-157.
40. Balasa VV, Gruppo RA, Glueck CJ, et al. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults. Thromb Haemost. 1999 ; 81: 739-744.
41. Glueck CJ, Iyengar S., Goldenberg N., Smith LS, Wang P. Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndrome. J Lab Clin Med. 2003 ; 142: 35-45.
42. Glueck CJ, Aregawi D., Goldenberg N., Golnik KC, Sieve L., Wang P. Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia. J Lab Clin Med. 2005 ; 145: 72-82.
43. Glueck CJ, Glueck HI, Tracy T., Speirs J., McCray C., Stroop D. Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer. Metabolism. 1993 ; 42: 236-246.
44. Glueck CJ, Freiberg RA, Fontaine RN, Tracy T., Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop Relat Res. 2001: 19-33.
45. Vossen CY, Walker ID, Svensson P., et al. Recurrence rate after a first venous thrombosis in patients with familial thrombophilia. Arterioscler Thromb Vasc Biol. 2005 ; 25: 1992-1997.
46. Makris M., Rosendaal FR, Preston FE Familial thrombophilia: genetic risk factors and management. J Intern Med Suppl. 1997 ; 740: 9-15.
47. Mainardi JR, Pelsma PM, Koning H., et al. Double-homozygosity for factor V Leiden and the prothrombin gene G20210A variant in a young patient with idiopathic venous thrombosis. Blood. 1999 ; 94: 1828-1829.
48. Liu XY, Gabig TG, Bang NU Combined heterozygosity of factor V leiden and the G20210A prothrombin gene mutation in a patient with cerebral cortical vein thrombosis. Am J Hematol. 2000 ; 64: 226-228.
49. Friedline JA, Ahmad E., Garcia D., et al. Combined factor V Leiden and prothrombin genotyping in patients presenting with thromboembolic episodes. Arch Pathol Lab Med. 2001 ; 125: 105-111.
50. Ehrenforth S., von Depka Prondsinski M., Aygoren-Pursun E., Nowak-Gottl U., Scharrer I., Ganser A. Study of the prothrombin gene 20201 GA variant in FV:Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolism. Arterioscler Thromb Vasc Biol. 1999 ; 19: 276-280.
51. Margaglione M., Brancaccio V., Giuliani N., et al. Increased risk for venous thrombosis in carriers of the prothrombin G→A20210 gene variant. Ann Intern Med. 1998 ; 129: 89-93.
52. Incorvaia C., Parmeggiani F., Costagliola C., et al. The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study. Graefes Arch Clin Exp Ophthalmol. 2001 ; 239: 251-256.
53. Bombeli T., Basic A., Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol. 2002 ; 70: 126-132.
54. Cheong JL, Bucknall R. Retinal vein thrombosis associated with a herbal phytoestrogen preparation in a susceptible patient. Postgrad Med J. 2005 ; 81: 266-267.
55. Holak HM, Holak NH, Holak S., Holak S. A. Szymaniec S. Retinal vein branch occlusion and palsy of the N abducens in protein S deficiency. Ophthalmologe. 2005 ; 102: 279-285.
56. Incorvaia C., Lamberti G., Parmeggiani F., et al. Idiopathic central retinal vein occlusion in a thrombophilic patient with the heterozygous 20210 G/A prothrombin genotype. Am J Ophthalmol. 1999 ; 128: 247-248.
57. Martinelli I. Unusual forms of venous thrombosis and thrombophilia. Pathophysiol Haemost Thromb. 2002 ; 32: 343-345.
58. Backhouse O., Parapia L., Mahomed I., Lee D. Familial thrombophilia and retinal vein occlusion. Eye. 2000 ; 14 (pt 1). 13-17.
59. Parodi MB Medical treatment of retinal vein occlusions. Semin Ophthalmol. 2004 ; 19: 43-48.
60. Suarez Baraza J., Calzado Hinojosa J., Caracena Ordonez JM, Miralles de Imperial J. Central retinal vein occlusion in a factor V leiden and G21210A prothrombin variant carrier. Arch Soc Esp Oftalmol. 2004 ; 79: 457-460.
61. Bick RL Antiphospholipid thrombosis syndromes. Hematol Oncol Clin North Am. 2003 ; 17: 115-147.
62. Ota R., Okisaka S. Effects of anticoagulant therapy on retinal vein occlusion. Nippon Ganka Gakkai Zasshi. 1995 ; 99: 955-958.